PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2020 | 14 | 2 |

Tytuł artykułu

Personalised medicine – best practices exchange and personal health implementation in European regions – a qualitative study concept under the Regions4PerMed (h2020) project

Treść / Zawartość

Warianty tytułu

Języki publikacji

EN

Abstrakty

EN
Personalised medicine (PM) is the adaptation of medical treatment to an individual patient. More importantly, PM offers the potential to detect disease earlier when it is easier to treat effectively. PM is beginning to overcome the limitations of traditional medicine. In PM there are many potential benefits and facilitators but also many barriers. The goals of the Regions4PerMed project are to set up the first interregional cooperation on PM, align strategies and financial instruments, and most importantly, identify primary barriers in personal medicine adoption in the health care system and systematic actions to remove as many of them as possible to create a future where PM is fully integrated into real life settings. Each key action activity will be followed by a focus group or semi-structured qualitative interview. The questions asked during the research will concern barriers and facilitators of PM implementation in the country of a subject and will concern: medical big data and electronic medical records; health technology in connected and integrated care; the health industry; facilitate the innovation flow in health care; socio-economic aspects. The qualitative study outcomes are supposed to bring more qualitative data to the discussion. They could be implemented to the daily practice of the health care system’s stakeholders through the best practices transferred to all five key strategic areas of the Regions4PerMed project.

Słowa kluczowe

Wydawca

-

Rocznik

Tom

14

Numer

2

Opis fizyczny

p.64-69,ref.

Twórcy

  • International Scientific Projects Section, Wroclaw Medical University, Wroclaw, Poland
  • Family Medicine Department, Wroclaw Medical University, Wroclaw, Poland
autor
  • International Scientific Projects Section, Wroclaw Medical University, Wroclaw, Poland

Bibliografia

  • 1. Garrod AE. Incidence of alkaptonuria: a study in chemical individuality. Lancet 1902; 2: 653–656.
  • 2. From One to One Hundred Thousand, 15th Anniversary of the Human Genome Project [online] 26 Jun 2015 [cit. 10.06.2020]. Available from URL: https://www.genomicsengland.co.uk/from-one-to-one-hundred-thousand.
  • 3. Graham E. Improving outcomes through personalised medicine, working at the cutting edge of science to improve patients’ lives [online] 7 Sep 2016 [cit. 10.06.2020]. Available from URL: https://www.england.nhs.uk/wp-content/uploads/2016/09/improving-outcomes-personalised-medicine.pdf.
  • 4. Regions4PerMed – Interregional coordination for a fast and deep uptake of personalised health [online] [cit. 10.06.2020]. Available from URL: https://www.regions4permed.eu.
  • 5. Personalised medicine: background, conference reports, publications and links related to personalise medicine [online] [cit. 10.06.2020]. Available from URL: https://ec.europa.eu/info/research-and-innovation/research-area/health-research-andinnovation/personalised-medicine_en.
  • 6. D’Errico G, Cormio PG, Bello P, Duda-Sikuła M, Zwiefka A, Krzyżanowski D, et al. Interregional coordination for a fast and deep uptake of personalised health (Regions4Permed) – multidisciplinary consortium under the H2020 project. MSP 2019; 13(3): 60–67.
  • 7. D’Errico G, Duda-Sikuła M, Zwiefka A, Krzyżanowski D, Kurpas D. Health technologies and smart & integrated care – key action 2 stage of the Regions4PerMed (H2020) project. MSP 2019; 13(4): 48–54.
  • 8. Kulynych J, Greely HT. Clinical genomics, big data, and electronic medical records: reconciling patient rights with research when privacy and science collide. J Law Biosci 2017 Apr; 4(1): 94–132.
  • 9. Panahiazar M, Taslimitehrani V, Jadhav A, Pathak J. Empowering personalized medicine with big data and semantic web technology: promises, challenges, and use cases. Proc IEEE Int Conf Big Data 2014 Oct; 2014: 790–795.
  • 10. Moss RJ, Süle A, Kohl S. eHealth and mHealth. Eur J Hosp Pharm 2019; 26: 57–58.
  • 11. Gleason AW. mHealth – opportunities for transforming global health care and barriers to adoption. Journal of Electronic Resources in Medical Libraries 2015; 12(2): 114–125.
  • 12. Grenier C, Pauget B, Hudebine H. Innovations in healthcare and wellbeing: a focus on actors and collaborations at the boundaries. Dans Journal of Innovation Economics & Management 2019; 3(30): 1–15.
  • 13. Manca A, Iglesias C. Stratified, personalised and precision medicine [online] [cit. 10.06.2020]. Available from URL: https://www.york.ac.uk/che/research/teehta/personalised-medicine.
  • 14. Roediger A. Personalised medicine: health economic aspects [online] 3 Apr 2013 [cit. 10.06.2020]. Available from URL: https://www.genengnews.com/magazine/personalizedmedicine-health-economic-aspects/4824/.
  • 15. Sairamesh Jakka S, Rossbach M. An economic perspective on personalized medicine. The HUGO Journal [online] 2013; 7: 1 [cit. 10.06.2020]. Available from URL: http://www.thehugojournal.com/content/7/1/1.
  • 16. Gibson G, Timlin A, Curran S, Wattis J. The scope for qualitative methods in research and clinical trials in dementia. Age Ageing 2004; 33: 422–426.
  • 17. DeJonckheere M, Vaughn LM. Semistructured interviewing in primary care research: a balance of relationship and rigour. Fam Med Com Health 2019; 7: e000057.
  • 18. Horgan D, Jansen M, Leyens L, A Lal J, Sudbrack R, Hackenitz E, et al. An index of barriers for the implementation of personalised medicine and pharmacogenomics in Europe. Public Health Genomics 2014; 17(5–6): 287–298.

Typ dokumentu

Bibliografia

Identyfikatory

Identyfikator YADDA

bwmeta1.element.agro-ec9f2f5f-161a-4644-b723-7f4aaaa5b49a
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.